ALK-

NET:ALK

ALK

  • Stock

Last Close

154.70

22/11 15:59

Market Cap

33.75B

Beta: -

Volume Today

65.48K

Avg: -

  • locale

    dkDenmark
  • market

    STOCKS
  • industry

    Pharmaceuticals
  • website

    alk.net
  • crunchbase

    alk-abello
  • linkedin

    alk-abello
  • founding date

    Jan 01, 1923
  • ipo date

    Mar 10, 2000

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets...Show More

peer of